Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: SurModics

Market Cap 43Cr 37Cr 34Cr 32Cr 60Cr 4.09TCr 61Cr 402.92Cr 156.66Cr 1.97TCr 160.43Cr 156.96Cr 6.84TCr P/E Ratio 2023
-292x
P/E Ratio 2024 -47.3x
Enterprise Value 42Cr 36Cr 33Cr 31Cr 59Cr 4.03TCr 60Cr 396.44Cr 154.14Cr 1.94TCr 157.85Cr 154.44Cr 6.73TCr EV / Sales 2023
3.33x
EV / Sales 2024 4.33x
Free-Float
99.63%
Yield 2023 *
-
Yield 2024 -
1 year 25.87
Extreme 25.87
43
3 years 22.15
Extreme 22.15
43
5 years 16
Extreme 16
62.27
10 years 16
Extreme 16
82.35
Manager TitleAgeSince
Chief Executive Officer 67 19/11/2025
Director of Finance/CFO 53 19/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 67 19/11/2025
Director/Board Member 53 19/11/2025
Date Insider Type Main position Quantity % Market Cap.
19/11Issuer sale

Director

35,847 0.2507%
19/11Issuer sale

Director

62,052 0.4340%
19/11Issuer sale

Director

51,877 0.3628%
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%-.--%+47.19%+92.05% 61Cr
+0.54%+3.06%-33.16%-11.84% 16TCr
+0.10%+3.05%-8.67%-4.06% 10TCr
+0.09%+6.77%-0.97%+57.94% 5.47TCr
-0.23%-6.71%+50.66%+49.87% 5.37TCr
-0.30%+1.19%-15.51%-41.41% 4.07TCr
+1.61%+7.72% - - 3.09TCr
+0.64%+3.41%-11.28%-39.48% 2.89TCr
-0.18%+4.44%+45.08%-5.15% 2.34TCr
-1.93%-0.66%-14.31%+2.17% 2.12TCr
Average +0.07%+2.33%+6.56%+11.12% 5.12TCr
Weighted average by Cap. +0.19%+2.29%-7.39%+1.55%

Financials

2023 2024
Net sales 13Cr 11Cr 11Cr 9.88Cr 19Cr 1.27TCr 19Cr 125Cr 49Cr 612.33Cr 50Cr 49Cr 2.12TCr 13Cr 11Cr 10Cr 9.4Cr 18Cr 1.21TCr 18Cr 118.87Cr 46Cr 582.28Cr 47Cr 46Cr 2.02TCr
Net income -15.36L -13.27L -12.2L -11.45L -21.45L -15Cr -21.81L -1.45Cr -56.31L -7.09Cr -57.66L -56.42L -25Cr -1.15Cr -99.71L -91.7L -86.04L -1.61Cr -110.51Cr -1.64Cr -11Cr -4.23Cr -53Cr -4.33Cr -4.24Cr -184.61Cr
Net Debt -1.21Cr -1.05Cr -96.14L -90.2L -1.69Cr -115.87Cr -1.72Cr -11Cr -4.44Cr -56Cr -4.54Cr -4.44Cr -193.55Cr -68.7L -59.35L -54.58L -51.21L -95.94L -66Cr -97.56L -6.48Cr -2.52Cr -32Cr -2.58Cr -2.52Cr -109.88Cr
Logo SurModics
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Employees
389
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. SRDX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!